Is Fertility Preservation Feasible and Safe With Neoadjuvant Therapy for Breast Cancer?

Avner Hershlag^{1

2}, Christine Mullin^{1

2}, Sara L Bristow^{1

2}

Affiliations

¹ Northwell Health, Manhasset, New Hyde, NY.
² Donald and Barabara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY.

Avner Hershlag et al. JCO Glob Oncol. 2020.

. 2020 Mar 2:6:356-359.

doi: 10.1200/GO.22.00008. eCollection 2020.

Avner Hershlag^{1

2}, Christine Mullin^{1

2}, Sara L Bristow^{1

2}

¹ Northwell Health, Manhasset, New Hyde, NY.
² Donald and Barabara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, NY.

No abstract available

Corrected and republished from

Is Fertility Preservation Feasible and Safe With Neoadjuvant Therapy for Breast Cancer?
Hershlag A, Mullin C, Bristow SL. Hershlag A, et al. J Glob Oncol. 2018 Apr 5;4:JGO.17.00213. doi: 10.1200/JGO.17.00213. eCollection 2018. J Glob Oncol. 2018. Corrected and republished in: JCO Glob Oncol. 2020 Nov;6:356-359. doi: 10.1200/GO.22.00008. PMID: 32259161 Free PMC article. Corrected and republished. No abstract available.

1. Schover LR, Rybicki LA, Martin BA, et al. : Having children after cancer. A pilot survey of survivors’ attitudes and experiences. Cancer 86:697-709, 1999 - PubMed
1. Hartman M, Liu J, Czene K, et al. : Birth rates among female cancer survivors: A population-based cohort study in Sweden. Cancer 119:1892-1899, 2013 - PubMed
1. Welt CK: Primary ovarian insufficiency: A more accurate term for premature ovarian failure. Clin Endocrinol (Oxf) 68:499-509, 2008 - PubMed
1. Bines J, Oleske DM, Cobleigh MA: Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer. J Clin Oncol 14:1718-1729, 1996 - PubMed
1. Petrek JA, Naughton MJ, Case LD, et al. : Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: A prospective study. J Clin Oncol 24:1045-1051, 2006 - PubMed